Capital Flow Monitor · Sponsors · CIK 2121301
Nula Therapeutics, Inc.
961 Arlington Ave N, St. Petersburg, FL, 33705 · 212-392-4735
Biotechnology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$7.4M
Sold
$7.4M
% sold
100.0%
Investors
7
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-18 | D ·current | 506(b) | $7.4M | $7.4M | 100.0% | 7 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Christopher Shepard — Executive Officer / Director, St. Petersburg, FL
- Jarod Rutledge — Director, St. Petersburg, FL
-
Nils Regge — Director, St. Petersburg, FL
1 other raise
- Aeovian Pharmaceuticals, Inc. $55.0M of $55.0M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.